Page last updated: 2024-08-23

simvastatin and Muscular Dystrophy, Duchenne

simvastatin has been researched along with Muscular Dystrophy, Duchenne in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (28.57)24.3611
2020's5 (71.43)2.80

Authors

AuthorsStudies
Dulak, J; Kaziród, K; Mucha, O; Podkalicka, P; Samborowska, E; Łoboda, A1
Aartsma-Rus, A; Verhaart, I; Wells, D1
Adams, ME; Bible, KL; Froehner, SC; Kim, MJ; Whitehead, NP2
Bertil-Froidevaux, E; Bordier, F; Bourg, N; Daniele, N; Georger, C; Guerchet, N; Israeli, D; Jaber, A; Lostal, W; Richard, I; Tanniou, G; Vu Hong, A1
Aartsma-Rus, A; Bull, D; Cappellari, O; Hildyard, JCW; Nnorom, S; Plomp, JJ; Tanganyika-de Winter, CL; Verhaart, IEC; Wells, DJ; Wells, KE1
Adams, ME; Bible, KL; Froehner, SC; Kim, MJ; Regnier, M; Whitehead, NP1

Other Studies

7 other study(ies) available for simvastatin and Muscular Dystrophy, Duchenne

ArticleYear
Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy.
    Skeletal muscle, 2021, 09-03, Volume: 11, Issue:1

    Topics: Animals; Disease Models, Animal; Dystrophin; Mice; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Simvastatin

2021
Author's Response to: Rebuttal to: Simvastatin Treatment Does Not Ameliorate Muscle Pathophysiology in a Mouse Model for Duchenne Muscular Dystrophy, Verhaart et al. 2020.
    Journal of neuromuscular diseases, 2021, Volume: 8, Issue:5

    Topics: Animals; Disease Models, Animal; Mice; Muscles; Muscular Dystrophy, Duchenne; Simvastatin

2021
Rebuttal to: Simvastatin Treatment Does Not Ameliorate Muscle Pathophysiology in a Mouse Model for Duchenne Muscular Dystrophy, Verhaart et al. 2020.
    Journal of neuromuscular diseases, 2021, Volume: 8, Issue:5

    Topics: Animals; Disease Models, Animal; Mice; Muscles; Muscular Dystrophy, Duchenne; Simvastatin

2021
Co-Administration of Simvastatin Does Not Potentiate the Benefit of Gene Therapy in the mdx Mouse Model for Duchenne Muscular Dystrophy.
    International journal of molecular sciences, 2022, Feb-11, Volume: 23, Issue:4

    Topics: Animals; Disease Models, Animal; Genetic Therapy; Male; Mice; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Simvastatin

2022
Simvastatin Treatment Does Not Ameliorate Muscle Pathophysiology in a Mouse Model for Duchenne Muscular Dystrophy.
    Journal of neuromuscular diseases, 2021, Volume: 8, Issue:5

    Topics: Animals; Disease Models, Animal; Fibrosis; Mice; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Simvastatin

2021
Simvastatin provides long-term improvement of left ventricular function and prevents cardiac fibrosis in muscular dystrophy.
    Physiological reports, 2019, Volume: 7, Issue:6

    Topics: Animals; Autonomic Nervous System; Calcium-Binding Proteins; Cardiomyopathies; Disease Models, Animal; Fibrosis; Heart; Heart Rate; Male; Mice, Inbred mdx; Muscular Dystrophy, Duchenne; Myocytes, Cardiac; Phosphorylation; Recovery of Function; Simvastatin; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling

2019
A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy.
    Proceedings of the National Academy of Sciences of the United States of America, 2015, Oct-13, Volume: 112, Issue:41

    Topics: Animals; Creatine Kinase; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Mice, Inbred mdx; Multienzyme Complexes; Muscle Fibers, Skeletal; Muscle Strength; Muscular Dystrophy, Duchenne; NADH, NADPH Oxidoreductases; Oxidation-Reduction; Simvastatin

2015